Mobile

A Phase 2 clinical trial of orally taken investigational product (called MLN9708) in adult patients with returning and/or not responding Follicular Lymphoma Ensayo clínico fase 2 del producto en...

Update Il y a 4 ans
Reference: EUCTR2013-002302-32

A Phase 2 clinical trial of orally taken investigational product (called MLN9708) in adult patients with returning and/or not responding Follicular Lymphoma Ensayo clínico fase 2 del producto en investigación (llamado MLN9708) que se administra por vía oral en pacientes adultos con linfoma folicular que recae y no responde

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective is to evaluate the anti-tumor activity of oral ixazomib as measured by ORR in adult patients with relapsed and/or refractory FL. El objetivo principal es evaluar la actividad antitumoral de MLN9708 oral medida mediante la tasa de respuestas globales (TRG) en pacientes adultos con linfoma folicular (LF) recidivante o refractario

Inclusion criteria

  • Follicular lymphoma,Linfoma Folicular

Links